Genetic Screening Boosts IVF Success Rates – Kolkata Experts
Unlocking Parenthood: How Genetic Screening is Revolutionizing IVF Success in 2025
Table of Contents
As of July 23, 2025, the landscape of assisted reproductive technology is experiencing a significant evolution, with genetic screening emerging as a pivotal factor in enhancing In Vitro fertilization (IVF) success rates. While the dream of parenthood has long been pursued through IVF,recent advancements,particularly in genetic testing,are offering unprecedented precision and hope to individuals and couples navigating this journey. This article delves into the science behind these breakthroughs, exploring how genetic screening is not just a supplementary tool but a foundational element for achieving healthier pregnancies and higher success rates in IVF cycles.
The Evolving Landscape of IVF: Beyond Basic Procedures
For decades, IVF has offered a beacon of hope for those facing infertility. The process, involving the fertilization of an egg by sperm outside the body, followed by the transfer of the resulting embryo into the uterus, has been refined over time. However,inherent challenges have persisted,including implantation failures,miscarriages,and the birth of children with genetic abnormalities. These challenges underscore the need for more sophisticated approaches that address the genetic integrity of embryos before transfer.
Understanding the Core IVF Process
Before diving into the advancements, it’s crucial to understand the fundamental steps of IVF:
Ovarian Stimulation: Medications are administered to stimulate the ovaries to produce multiple eggs.
Egg Retrieval: Mature eggs are surgically retrieved from the ovaries.
Sperm Collection and Preparation: A sperm sample is collected and processed to select the most viable sperm.
Fertilization: Eggs and sperm are combined in a laboratory dish to achieve fertilization.
Embryo culture: Fertilized eggs (embryos) are cultured in the lab for several days.
Embryo Transfer: One or more embryos are transferred into the woman’s uterus.
Pregnancy Test: A blood test is conducted to determine if pregnancy has occurred.
The Limitations of Traditional IVF
Despite its successes, traditional IVF is not without its limitations. A significant percentage of IVF cycles still do not result in a live birth. Several factors contribute to this, including:
Embryo Quality: Not all embryos are created equal. Some may have chromosomal abnormalities that prevent them from implanting or developing properly.
Uterine Habitat: While crucial, the uterine environment can sometimes be unreceptive to even genetically normal embryos.
Age and Underlying Health Conditions: the age of the woman and various health factors can influence success rates.
It is in addressing the critical aspect of embryo quality that genetic screening has made its most profound impact.
Genetic Screening: A New Era of Precision in IVF
Genetic screening in IVF refers to the testing of embryos for chromosomal abnormalities before they are transferred to the uterus. This practice, often referred to as Preimplantation Genetic Testing (PGT), has evolved significantly, offering different types of analysis tailored to specific concerns.
Preimplantation genetic Testing (PGT): A Deeper Dive
PGT is an umbrella term encompassing several specialized tests:
PGT-A (Preimplantation Genetic testing for Aneuploidy): This is the most commonly performed type of PGT. Aneuploidy refers to an abnormal number of chromosomes. most human embryos with aneuploidy are not viable and will either fail to implant or result in a miscarriage. PGT-A screens embryos for common chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), as well as other numerical chromosome imbalances. By identifying chromosomally normal embryos, PGT-A aims to increase implantation rates and reduce the risk of miscarriage. PGT-M (Preimplantation Genetic testing for Monogenic/single Gene Defects): This test is used for couples who are known carriers of specific inherited genetic disorders caused by a mutation in a single gene. Examples include cystic fibrosis,Huntington’s disease,sickle cell anemia,and Tay-Sachs disease. PGT-M allows for the selection of embryos that are not affected by the specific genetic condition, thereby preventing the transmission of the disorder to the child. this requires prior identification of the specific gene mutation in the parents.
* PGT-SR (Preimplantation Genetic Testing for structural Rearrangements): This